First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...

Emergency department patients with alcohol use disorder who report higher readiness-to-change scores are more likely to ...

Exposure to high greenness levels is linked to decreased risk for hospital admissions for mental health disorders, especially ...

Clinically diagnosed pruritus significantly affected fatigue and antidepressant use in adults with primary sclerosing ...

Between 2008 and 2018, more than 10,000 Italian physicians moved abroad, with the UK (33%) and Switzerland (26%) as top ...

Proponents of narrative-based medicine say that it offers clinicians and medical students an opportunity to restore empathy ...

A joint procurement contract between the EU and Danish manufacturer Bavarian Nordic strengthens vaccine preparedness against ...

Three cancer therapies were among the first two batches of drugs to receive vouchers through a new FDA program.

Patients with type 2 diabetes and a preexisting severe mental illness are prescribed metformin and insulin sooner after ...

The MHRA has approved inavolisib for adults with PIK3CA-mutated HR+/HER2– breast cancer, offering a new targeted first-line ...

The long-awaited Canadian approval of lecanemab has shifted physicians’ approach to Alzheimer’s disease, addressing previous ...

An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...